AAAAAA

   
Results: 1-10 |
Results: 10
PHARMACOKINETIC INTERACTIONS WITH FELBAMATE - IN-VITRO IN-VIVO CORRELATION
Authors: GLUE P BANFIELD CR PERHACH JL MATHER GG RACHA JK LEVY RH
Citation: P. Glue et al., PHARMACOKINETIC INTERACTIONS WITH FELBAMATE - IN-VITRO IN-VIVO CORRELATION, Clinical pharmacokinetics, 33(3), 1997, pp. 214-224
LACK OF EFFECT OF AZELASTINE AND KETOCONAZOLE COADMINISTRATION ON ELECTROCARDIOGRAPHIC PARAMETERS IN HEALTHY-VOLUNTEERS
Authors: MORGANROTH J LYNESS WH PERHACH JL MATHER GG HARR JE TRAGER WF LEVY RH ROSENBERG A
Citation: J. Morganroth et al., LACK OF EFFECT OF AZELASTINE AND KETOCONAZOLE COADMINISTRATION ON ELECTROCARDIOGRAPHIC PARAMETERS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(11), 1997, pp. 1065-1072
INFLUENCE OF STIRIPENTOL ON CYTOCHROME P450-MEDIATED METABOLIC PATHWAYS IN HUMANS - IN-VITRO AND IN-VIVO COMPARISON AND CALCULATION OF IN-VIVO INHIBITION CONSTANTS
Authors: TRAN A REY E PONS G ROUSSEAU M DATHIS P OLIVE G MATHER GG BISHOP FE WURDEN CJ LABROO R TRAGER WF KUNZE KL THUMMEL KE VINCENT JC GILLARDIN JM LEPAGE F LEVY RH
Citation: A. Tran et al., INFLUENCE OF STIRIPENTOL ON CYTOCHROME P450-MEDIATED METABOLIC PATHWAYS IN HUMANS - IN-VITRO AND IN-VIVO COMPARISON AND CALCULATION OF IN-VIVO INHIBITION CONSTANTS, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 490-504
LACK OF HUMAN CYP450 INHIBITION BY TIZANIDINE AND 2 MAJOR METABOLITES
Authors: MATHER GG HARR JH HARGREAVES JA TRAGER WF LEVY RH
Citation: Gg. Mather et al., LACK OF HUMAN CYP450 INHIBITION BY TIZANIDINE AND 2 MAJOR METABOLITES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 9-9
EXPLANATION AND PREDICTION OF DRUG-INTERACTIONS WITH TOPIRAMATE USINGA CYP450 INHIBITION SPECTRUM
Authors: LEVY RH BISHOP F STREETER AJ TRAGER WF KUNZE KL THUMMEL KT MATHER GG
Citation: Rh. Levy et al., EXPLANATION AND PREDICTION OF DRUG-INTERACTIONS WITH TOPIRAMATE USINGA CYP450 INHIBITION SPECTRUM, Epilepsia, 36, 1995, pp. 252-252
PREDICTION OF POTENTIAL-DRUG INTERACTIONS USING CYP450 INHIBITION SPECTRA FOR D2916 AND D3187
Authors: MATHER GG KUNZE KL HARR JE LEPAGE F LEVY RH
Citation: Gg. Mather et al., PREDICTION OF POTENTIAL-DRUG INTERACTIONS USING CYP450 INHIBITION SPECTRA FOR D2916 AND D3187, Epilepsia, 36, 1995, pp. 253-253
HUMAN AND RAT-METABOLISM OF D2916 AND ANTICONVULSANT PROPERTIES OF ITS METABOLITES
Authors: LEPAGE F GILLARDIN JM TOMBRET F GIRARD P DESCOMBE JJ TANG C MATHER GG LEVY RH BAILLIE TA
Citation: F. Lepage et al., HUMAN AND RAT-METABOLISM OF D2916 AND ANTICONVULSANT PROPERTIES OF ITS METABOLITES, Epilepsia, 36, 1995, pp. 261-261
VALPROATE (VPA) INTERACTION WITH ENDOTOXIN AND TNF
Authors: STEPHENS JR MATHER GG LEVY RH
Citation: Jr. Stephens et al., VALPROATE (VPA) INTERACTION WITH ENDOTOXIN AND TNF, Epilepsia, 36, 1995, pp. 265-265
MECHANISMS OF STIRIPENTOL INTERACTIONS WITH CARBAMAZEPINE AND PHENYTOIN
Authors: MATHER GG BISHOP FE TRAGER WF KUNZE KK THUMMEL KE SHEN DD ROSKOS LK LEPAGE F GILLARDIN JM LEVY RH
Citation: Gg. Mather et al., MECHANISMS OF STIRIPENTOL INTERACTIONS WITH CARBAMAZEPINE AND PHENYTOIN, Epilepsia, 36, 1995, pp. 162-163
CHARACTERIZATION OF A CHEMICALLY-INDUCED TUMOR-MODEL AND THE EFFECTS OF NATURAL-KILLER-CELL DEPLETION BY ANTIASIALO GM-1
Authors: MATHER GG TALCOTT PA EXON JH
Citation: Gg. Mather et al., CHARACTERIZATION OF A CHEMICALLY-INDUCED TUMOR-MODEL AND THE EFFECTS OF NATURAL-KILLER-CELL DEPLETION BY ANTIASIALO GM-1, Immunobiology, 190(4-5), 1994, pp. 333-345
Risultati: 1-10 |